Maryland Department of
Health Shares Prescribing Information on Controlled Substances
(December 3, 2018) – As part of Governor Larry Hogan’s fight against the
heroin and opioid epidemic in Maryland, effective July 1, 2018, health care
prescribers and pharmacists are required to check the Prescription Drug
Monitoring Program (PDMP) in certain
prescribing or dispensing situations, such as before beginning a new
course of treatment with opioids or benzodiazepines. The Hogan Administration championed
legislation expanding the PDMP with this requirement,
as well as requiring mandatory registration for all providers that have a
license to prescribe or dispense controlled dangerous substances.
July 1, 2018, dispensing information on drugs that contain controlled dangerous
substances (CDS) has been shared with health care providers at the point of
care more than 1,000,000 times per month.
prescription information improves the ability for health care prescribers and
pharmacists to manage the benefits and risks of controlled substance
medications and to identify potentially harmful drug interactions,” said Maryland
Department of Health Secretary Robert R. Neall.
PDMP, implemented by the
Maryland Department of Health’s Behavioral Health Administration, collects and
securely stores information on drugs that contain CDS and are dispensed to
patients in Maryland. Drug dispensers — health care providers and pharmacists —
electronically report the information that is stored in the PDMP database.
to prescription data is made available at no cost to health care providers and
pharmacists through the Chesapeake Regional Information System (CRISP),
Maryland’s state-designated health information exchange. The information is
delivered through the secure, web-based portal and directly within electronic
health record systems. The number of prescription data accessed has more than
doubled over the last six months, with almost 250,000 queries each week. This
accomplishment is a result of PDMP and CRISP prioritizing innovative methods of
delivering PDMP data within the electronic workflow.
addition to partnering with CRISP, collaboration between MedChi-The Maryland
State Medical Society, the Maryland Hospital Association, and patient advocates
has helped with the success of this important program.
Fighting the heroin and
opioid epidemic in Maryland has been a top priority of the Hogan-Rutherford
administration. The Maryland Department of Health, in partnership with the
Opioid Operational Command Center, and other state agencies, continues to
collaborate with federal, state, and local partners to fight to reduce the
number of overdoses and resulting fatalities in a multitude of ways, among them
Marylanders who need help
finding substance use disorder treatment resources should visit http://goo.gl/nIfGm0 or call Maryland Crisis Connect, which provides 24/7 support, at 211,
press 1. For information on many of the policies currently implemented to fight
addiction and overdose in Maryland, see http://goo.gl/KvEzQw. If you know of someone in need of treatment for a substance use
disorder, treatment facilities can be located by location and program
characteristics on our page at http://goo.gl/rbGF6S.
The Maryland Department of Health is the State agency that
protects Maryland’s public health. We work together to promote and improve the
health and safety of all Marylanders through disease prevention, access to
care, quality management, and community engagement. Stay connected: http://www.twitter.com/MDHealthDept and http://www.facebook.com/MarylandDHMH.
201 W. Preston Street, Baltimore, MD 21201-2399
(410) 767-6500 or 1-877-463-3464